Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Mar;76(3):215–218. doi: 10.1136/adc.76.3.215

Response to influenza virus vaccination in vertical HIV infection

E Lyall 1, A Charlett 1, P Watkins 1, M Zambon 1
PMCID: PMC1717114  PMID: 9135261

Abstract

Accepted 4 November 1996


OBJECTIVE—To assess the antibody response to influenza vaccine of children vertically infected with HIV.
DESIGN—Prospective study in HIV infected children vaccinated during the winter of 1994-5.
SETTING—Family HIV clinic at St Mary's Hospital, Paddington.
SUBJECTS—25 children, aged 1-11 years, vertically infected with HIV.
MAIN OUTCOME MEASURES—Responses to influenza antigens (H1N1-A /Taiwan /1/86, H3N2-A /Shandong /9/93, B /Panama /45/90) were tested by haemagglutination inhibition. Antibody responses were assessed according to clinical symptoms and immune function, stratified according to the 1994revised classification for HIV infection in children.
RESULTS—23 children (92%) had either very low or no detectable antibody before vaccination. New protective antibody responses were made by 10 children (40%): in seven to a single antigen, in two to two antigens, and in one to all three antigens. For each antigen there was an overall small increase in the mean geometric titre of antibody produced, but this only reached a protective level for antigen H1N1 and for children with minimal symptoms. Less symptomatic children were significantly more likely to produce a protective antibody response to influenza vaccination. No association was found between immune function, as measured by CD4 count, and vaccine response.
CONCLUSIONS—Only vaccination of the least symptomatic HIV infected children against influenza is likely to be effective. This will not only protect them against influenza, but will also protect other more immunosuppressed and vulnerable members of their families.



Full Text

The Full Text of this article is available as a PDF (82.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein D. I., Cherry J. D. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults. Am J Dis Child. 1983 Jul;137(7):622–626. doi: 10.1001/archpedi.1983.02140330006003. [DOI] [PubMed] [Google Scholar]
  2. Chadwick E. G., Chang G., Decker M. D., Yogev R., Dimichele D., Edwards K. M. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1994 Mar;13(3):206–211. doi: 10.1097/00006454-199403000-00008. [DOI] [PubMed] [Google Scholar]
  3. Clover R. D., Crawford S., Glezen W. P., Taber L. H., Matson C. C., Couch R. B. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991 Feb;163(2):300–304. doi: 10.1093/infdis/163.2.300. [DOI] [PubMed] [Google Scholar]
  4. Groothuis J. R., Levin M. J., Rabalais G. P., Meiklejohn G., Lauer B. A. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics. 1991 Jun;87(6):823–828. [PubMed] [Google Scholar]
  5. Gruber W. C., Taber L. H., Glezen W. P., Clover R. D., Abell T. D., Demmler R. W., Couch R. B. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990 May;144(5):595–600. doi: 10.1001/archpedi.1990.02150290089035. [DOI] [PubMed] [Google Scholar]
  6. Hall C. B. Influenza: a shot or not? Pediatrics. 1987 Apr;79(4):564–566. [PubMed] [Google Scholar]
  7. Kempe A., Hall C. B., MacDonald N. E., Foye H. R., Woodin K. A., Cohen H. J., Lewis E. D., Gullace M., Gala C. L., Dulberg C. S. Influenza in children with cancer. J Pediatr. 1989 Jul;115(1):33–39. doi: 10.1016/s0022-3476(89)80325-7. [DOI] [PubMed] [Google Scholar]
  8. Mauch T. J., Bratton S., Myers T., Krane E., Gentry S. R., Kashtan C. E. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics. 1994 Aug;94(2 Pt 1):225–229. [PubMed] [Google Scholar]
  9. O'Brien W. A., Grovit-Ferbas K., Namazi A., Ovcak-Derzic S., Wang H. J., Park J., Yeramian C., Mao S. H., Zack J. A. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 1995 Aug 1;86(3):1082–1089. [PubMed] [Google Scholar]
  10. Yerly S., Wunderli W., Wyler C. A., Kaiser L., Hirschel B., Suter S., Perrin L. H., Siegrist C. A. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. AIDS. 1994 Oct;8(10):1503–1504. doi: 10.1097/00002030-199410000-00022. [DOI] [PubMed] [Google Scholar]
  11. Zuckerman M. A., Wood J., Chakraverty P., Taylor J., Heath A. B., Oxford J. S. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol. 1991 Feb;33(2):133–137. doi: 10.1002/jmv.1890330213. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES